These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16155790)

  • 41. Breast cancer and duration of tamoxifen.
    Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Education and imaging: hepatobiliary and pancreatic: focal steatohepatitis mimicking a metastasis.
    Choi JS; Kim MJ
    J Gastroenterol Hepatol; 2011 Feb; 26(2):415. PubMed ID: 21261737
    [No Abstract]   [Full Text] [Related]  

  • 43. Branch retinal vein occlusion associated with tamoxifen use.
    Onder Hİ; Kilic AC; Kose SA; Karatas A; Kaya E; Kaya M; Tunc M
    Semin Ophthalmol; 2013 Mar; 28(2):88-90. PubMed ID: 23448563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Future endocrine therapy of breast cancer].
    Ejlertsen B
    Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
    [No Abstract]   [Full Text] [Related]  

  • 45. Benefit/risk assessment of SERM therapy: clinical trial versus clinical practice settings.
    Costantino JP
    Ann N Y Acad Sci; 2001 Dec; 949():280-5. PubMed ID: 11795363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL; Cheng MH; Chao HT; Wang PH
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
    Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
    Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy.
    Eisner A; O'Malley JP; Incognito LJ; Toomey MD; Samples JR
    Curr Eye Res; 2006 Apr; 31(4):367-79. PubMed ID: 16603470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemo brain, antiestrogens, and me.
    Simmons CC
    Clin J Oncol Nurs; 2009 Jun; 13(3):253-4. PubMed ID: 19502180
    [No Abstract]   [Full Text] [Related]  

  • 52. Some antidepressants interfere with tamoxifen more than others.
    Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970
    [No Abstract]   [Full Text] [Related]  

  • 53. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review.
    Bender CM; Paraska KK; Sereika SM; Ryan CM; Berga SL
    J Pain Symptom Manage; 2001 May; 21(5):407-24. PubMed ID: 11369162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
    Reid-Arndt SA
    Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
    Raffa RB
    J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant therapy of breast cancer - bisphosphonates.
    Saarto T
    Cancer Treat Res; 2009; 151():163-77. PubMed ID: 19593512
    [No Abstract]   [Full Text] [Related]  

  • 57. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P; Marty M
    Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tamoxifen-induced radiation recall dermatitis.
    Singer EA; Warren RD; Pennanen MF; Collins BT; Hayes DF
    Breast J; 2004; 10(2):170-1. PubMed ID: 15009054
    [No Abstract]   [Full Text] [Related]  

  • 59. "Doctor, will the treatment you are recommending cause chemobrain?".
    Ganz PA
    J Clin Oncol; 2012 Jan; 30(3):229-31. PubMed ID: 22184392
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychostimulants for chemotherapy induced cognitive changes in cancer, Ockham's razor, anyone?
    Dutta V
    J Cancer Res Ther; 2012; 8(2):326-9. PubMed ID: 22842390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.